Actelion (now Janssen Pulmonary Hypertension)
Overview
Actelion (now Janssen Pulmonary Hypertension) is a pharmaceutical company headquartered in Basel, Switzerland, founded in 1997, with approximately 1,001 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Actelion (now Janssen Pulmonary Hypertension) in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.